Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 76.83
-4.96 %
$ 5.34 B
Market Cap
12.76
P/E
CASH FLOW STATEMENT
305 M
OPERATING CASH FLOW
5.94 M
INVESTING CASH FLOW
-13.1 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Lantheus Holdings, Inc.
| Net Income | 327 M |
| Depreciation & Amortization | 60 M |
| Capital Expenditures | -46.6 M |
| Stock-Based Compensation | 50.5 M |
| Change in Working Capital | -171 M |
| Others | 10.5 M |
| Free Cash Flow | 259 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | 326.7 | 28.1 | (71.3) | (13.5) | 31.7 | 40.5 | 123.4 | 26.8 | (14.7) | (3.6) | (61.6) | (42.0) | (137.3) |
| Depreciation & Amortization | 60.0 | 47.9 | 42.3 | 24.7 | 13.4 | 13.9 | 19.2 | 18.3 | 19.7 | 18.3 | 25.2 | 27.4 | 32.8 |
| Deferred Income Tax | (54.8) | (50.9) | 3.6 | (0.7) | 7.2 | 6.1 | (92.6) | 0.4 | 0.9 | 0.2 | (0.7) | 0.4 | 81.7 |
| Stock Based Compensation | 50.5 | 29.3 | 15.9 | 14.1 | 12.5 | 8.7 | 5.9 | 2.5 | 2.0 | 1.0 | 0.6 | 1.2 | (1.0) |
| Other Operating Activities | 94.1 | 302.5 | 78.5 | 14.2 | 6.6 | 5.9 | 7.1 | (0.4) | 22.2 | 7.6 | 32.4 | 17.4 | 60.9 |
| Change in Working Capital | (171.2) | (75.1) | (15.2) | (22.4) | 9.0 | (14.0) | (8.3) | 2.1 | (8.2) | (11.8) | (11.5) | (4.8) | (14.0) |
| Cash From Operations | 305.3 | 281.8 | 53.9 | 16.4 | 80.4 | 61.2 | 54.8 | 49.6 | 21.8 | 11.6 | (15.6) | (0.4) | 23.2 |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | (46.6) | (18.3) | (12.1) | (12.5) | (22.1) | (20.1) | (17.5) | (7.4) | (13.2) | (8.1) | (5.0) | (7.9) | (7.7) |
| Other Items | 52.5 | (258.2) | 15.8 | 7.6 | 0 | 1.0 | 1.2 | 10.7 | 0 | 0.5 | 1.5 | (0.2) | 0 |
| Cash From Investing Activities | 5.9 | (276.5) | 3.7 | (4.9) | (22.1) | (19.1) | (16.3) | 3.3 | (13.2) | (7.7) | (3.5) | (8.1) | (7.7) |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | 0 | (75.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | (0.2) | (44.1) |
| Total Debt Repaid | (0.7) | 382.4 | (43.3) | (15.5) | (78.2) | (2.9) | (14.0) | (78.7) | (65.5) | (2.3) | 5.4 | (1.5) | 152.2 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | (3.5) | (101.1) |
| Other Financing Activities | (14.3) | 3.0 | 3.2 | (7.1) | (1.3) | (2.2) | 0.3 | (2.4) | (7.0) | 13 K | 0 | (0.4) | (53.2) |
| Cash From Financing Activities | (13.1) | 311.7 | (39.3) | (21.9) | (78.9) | (4.7) | (13.4) | (30.2) | 1.0 | (2.3) | 5.6 | (5.1) | (2.2) |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | 298.0 | 316.6 | 18.0 | (10.2) | (20.5) | 37.1 | 25.1 | 22.6 | 8.9 | 1.2 | (14.7) | (13.0) | 13.2 |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | 258.7 | 263.4 | 41.8 | 3.9 | 58.3 | 41.1 | 37.2 | 42.2 | 8.6 | 3.5 | (20.6) | (8.3) | 15.5 |